206 related articles for article (PubMed ID: 35033701)
1. Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients.
Zein JG; Strauss R; Attaway AH; Hu B; Milinovich A; Jawhari N; Chamat SS; Ortega VE
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):742-750.e14. PubMed ID: 35033701
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019.
Strauss R; Jawhari N; Attaway AH; Hu B; Jehi L; Milinovich A; Ortega VE; Zein JG
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):3934-3940.e9. PubMed ID: 34438103
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic's COVID-19 registry.
Sen P; Majumdar U; Zein J; Hatipoğlu U; Attaway AH
PLoS One; 2021; 16(6):e0252576. PubMed ID: 34081722
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
[TBL] [Abstract][Full Text] [Related]
5. Association between inhaled corticosteroid use and COVID-19 outcomes.
Husby A; Pottegård A; Hviid A
Pharmacoepidemiol Drug Saf; 2021 Nov; 30(11):1486-1492. PubMed ID: 34390285
[TBL] [Abstract][Full Text] [Related]
6. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
[TBL] [Abstract][Full Text] [Related]
7. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
8. Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.
Labor M; Kirui BK; Nyberg F; Vanfleteren LEGW
Int J Chron Obstruct Pulmon Dis; 2023; 18():1701-1712. PubMed ID: 37576828
[TBL] [Abstract][Full Text] [Related]
9. Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.
Oshagbemi OA; Franssen FME; Braeken DCW; Henskens Y; Wouters EFM; Maitland-van der Zee AH; Burden AM; de Vries F
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1191-1199. PubMed ID: 30264901
[TBL] [Abstract][Full Text] [Related]
10. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
[TBL] [Abstract][Full Text] [Related]
11. Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study.
Bloom CI; Cullinan P; Wedzicha JA
Am J Respir Crit Care Med; 2022 Jan; 205(1):36-45. PubMed ID: 34669568
[No Abstract] [Full Text] [Related]
12. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
[TBL] [Abstract][Full Text] [Related]
13. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
Harries TH; Rowland V; Corrigan CJ; Marshall IJ; McDonnell L; Prasad V; Schofield P; Armstrong D; White P
Respir Res; 2020 Jan; 21(1):3. PubMed ID: 31900184
[TBL] [Abstract][Full Text] [Related]
14. The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis.
Chen CH; Wang CY; Chen CY; Wang YH; Chen KH; Lai CC; Wei YF; Fu PK
PLoS One; 2024; 19(1):e0295366. PubMed ID: 38241229
[TBL] [Abstract][Full Text] [Related]
15. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
[No Abstract] [Full Text] [Related]
16. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
Suissa S; Dell'Aniello S; Ernst P
Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
[TBL] [Abstract][Full Text] [Related]
17. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
Pavord ID; Lettis S; Anzueto A; Barnes N
Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
[TBL] [Abstract][Full Text] [Related]
18. Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis.
Oshagbemi OA; Odiba JO; Daniel A; Yunusa I
Curr Drug Targets; 2019; 20(16):1670-1679. PubMed ID: 31393244
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids for the treatment of COVID-19.
Griesel M; Wagner C; Mikolajewska A; Stegemann M; Fichtner F; Metzendorf MI; Nair AA; Daniel J; Fischer AL; Skoetz N
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD015125. PubMed ID: 35262185
[TBL] [Abstract][Full Text] [Related]
20. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.
Calmes D; Graff S; Maes N; Frix AN; Thys M; Bonhomme O; Berg J; Debruche M; Gester F; Henket M; Paulus V; Duysinx B; Heinen V; Dang DN; Paulus A; Quaedvlieg V; Vaillant F; Van Cauwenberge H; Malaise M; Gilbert A; Ghuysen A; Gillet P; Moutschen M; Misset B; Sibille A; Guiot J; Corhay JL; Louis R; Schleich F
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):160-169. PubMed ID: 33038592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
